Design and synthesis of 2-substituted-5-(4-trifluoromethylphenyl-sulphonamido)benzoxazole derivatives as human GST P1-1 inhibitors

References

• Josephy PD, Mannervik B. Molecular toxicology. 2nd ed. New York (NY): Oxford University Press; 2006.
   Google Scholar
• Mathew N, Kalyanasundaram M, Balaraman K. Glutathione S-transferase (GST) inhibitors. Expert Opin Ther Pat. 2006;16:431–444.
   Web of Science ®Google Scholar
• Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51–88.
   PubMed Web of Science ®Google Scholar
• Kazemnejad S, Rasmi Y, Sharifi R, et al. Class-Pi of glutathione S-transferases. Iran J Biotechnol. 2006;4(1):1–16.
   Google Scholar
• Ban N, Takahashi Y, Takayama T, et al. Transfection of glutathione S-transferase (GST)-pi antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide. Cancer Res. 1996;56:3577–3582.
   PubMed Web of Science ®Google Scholar
• Morrow CS, Smitherman PK, Diah SK, et al. Coordinated action of glutathione S-transferases (GSTs) and multidrug resistance protein 1 (MRP1) in antineoplastic drug detoxification. Mechanism of GST A1-1- and MRP1-associated resistance to chlorambucil in MCF7 breast carcinoma cells. Biol Chem. 1998;273:20114–20120.
   Web of Science ®Google Scholar
• Ruzza P, Calderan A. Glutathione transferase (GST)-activated prodrugs. Pharmaceutics. 2013;5:220–231.
   PubMedGoogle Scholar
• Adler V, Yin Z, Fuchs SY, et al. Regulation of JNK signaling by GSTp. EMBO J. 1999;18:1321–1334.
   PubMed Web of Science ®Google Scholar
• Asakura T, Sasagawa A, Takeuchi H, et al. Conformational change in the active center region of GST P1-1, due to binding of a synthetic conjugate of DXR with GSH, enhanced JNK-mediated apoptosis. Apoptosis. 2007;12:1269–1280.
   PubMed Web of Science ®Google Scholar
• Mulder TP, Peters WH, Wobbes T, et al. Measurement of glutathione S-transferase P1-1 in plasma: pitfalls and significance of screening and follow-up of patients with gastrointestinal carcinoma. Cancer. 1997;80:873–880.
   PubMed Web of Science ®Google Scholar
• Oakley AJ, Lo Bello M, Battistoni A, et al. The structures of human glutathione transferase P1-1 in complex with glutathione and various inhibitors at high resolution. J Mol Biol. 1997;274:84–100.
   PubMed Web of Science ®Google Scholar
• Koeplinger KA, Zhao Z, Peterson T, et al. Activated sulfonamides are cleaved by glutathione-S-transferases. Drug Metab Dispos. 1999;27:986–991.
   PubMed Web of Science ®Google Scholar
• Kodera Y, Akiyama S, Isobe K, et al. Expression of pi-glutathione s-transferase gene (GSTP1) in gastric cancer: lack of correlation with resistance against cis-diamminedichloroplatinum (II). Eur J Cancer. 1994;30A(14):2158–2162.
   PubMed Web of Science ®Google Scholar
• Axarli I, Labrou NE, Petrou C, et al. Sulphonamide-based bombesin prodrug analogues for glutathione transferase, useful in targeted cancer chemotherapy. Eur J Med Chem. 2009;44:2009–2016.
   PubMed Web of Science ®Google Scholar
• Musdal Y, Ertan-Bolelli T, Bolelli K, et al. Inhibition of human glutathione transferase P1-1 by novel benzazole derivatives. Turk J Biochem. 2012;37:431–436.
   Web of Science ®Google Scholar
• Ertan-Bolelli T, Musdal Y, Bolelli K, et al. Synthesis and biological evaluation of 2-substituted-5-(4-nitrophenylsulfonamido)benzoxazoles as human GST P1-1 inhibitors, and description of the binding site features. ChemMedChem. 2014;9:984–992.
   PubMed Web of Science ®Google Scholar
• Oakley AJ, Rossjohn J, Lo Bello M, et al. The three-dimensional structure of the human Pi class glutathione transferase P1-1 in complex with the inhibitor ethacrynic Acid and Its glutathione conjugate. Biochemistry. 1997;36:576–585.
   PubMed Web of Science ®Google Scholar
• Dassault Systèmes BIOVIA [Internet]. San Diego (CA): BIOVIA Discovery Studio Modeling Environment; c2002–2017 [cited 2017 Feb 18]. Available from: http://accelrys.com/products/collaborative-science/biovia-discovery-studio/
   Google Scholar
• Wu G, Robertson DH, Brooks CL, et al. Detailed analysis of grid-based molecular docking: a case study of CDOCKER-A CHARMm-based MD docking algorithm. J Comput Chem. 2003;24:1549–1562.
   PubMed Web of Science ®Google Scholar
• Yildiz-Oren I, Tekiner-Gulbas B, Yalcin I, et al. Synthesis and antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substitutedcarbonylamino]-benzoxazoles. Arch Pharm. 2004;337(7):402–410.
   PubMed Web of Science ®Google Scholar
• Wynne GM, Wren SP, Johnson PD, et al. Summit Corporation Plc. Treatment of Duchenne muscular dystrophy. Patent no. WO2007091106 A2, 2007 Aug 16.
   Google Scholar
• Kolm RH, Stenberg G, Widersten M, et al. High-level bacterial expression of human glutathione transferase P1-1 encoded by semisynthetic DNA. Protein Expr Purif. 1995;6:265–271.
   PubMed Web of Science ®Google Scholar
• Mannervik B, Guthenberg C. Glutathione transferase (human placenta). Meth Enzymol. 1981;77:231–235.
   PubMedGoogle Scholar
• Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974;249:7130–7139.
   PubMed Web of Science ®Google Scholar
• Quesada-Soriano I, Parker LJ, Primavera A, et al. Influence of the H-site residue 108 on human glutathione transferase P1-1 ligand binding: structure-thermodynamic relationships and thermal stability. Protein Sci. 2009;18:2454–2470.
   PubMed Web of Science ®Google Scholar
• Sener E, Yalcin I, Ozden S, et al. Synthesis and antimicrobial activities of 5-amino-2-(p-substitutedphenyl)benzoxazole derivatives. Turk J Med Pharm. 1987;11(3):391–396.
   Google Scholar